Impact of Endophthalmitis on the Risk of Acute Myocardial Infarction in Ankylosing Spondylitis Patients: A Population-Based Retrospective Cohort Study.
Ting Yi LinYi-Fen LaiWu-Chien ChienYi-Hao ChenChi-Hsiang ChungJiann-Torng ChenChing-Long ChenPublished in: Journal of clinical medicine (2023)
Many studies have demonstrated an increased cardiovascular (CV) risk in ankylosing spondylitis (AS) patients. Nevertheless, the influence of an endophthalmitis episode toward the future risks of acute myocardial infarction (AMI) in AS patients has been unclear. The objective of this study was to explore the impact of endophthalmitis on AMI risk in this particular patient population by a population-based retrospective cohort study with a follow-up period up to 16 years. Univariate and multivariate Cox regression analyses were used for the risk evaluation and the results were presented as crude and adjusted hazard ratios (HRs). Overall, we enrolled 557 AS patients with endophthalmitis as the study cohort and selected another 2228 matched AS patients without endophthalmitis as the comparison cohort. Comparing the comparison cohort, the study cohort showed a significantly higher overall AMI incidence rate with an adjusted HR of 1.631 ( p < 0.001). In conclusion, endophthalmitis increased the risk of AMI in AS patients after adjusting for possible clinical confounders. Special attention and work-up are required for physicians when encountering a history of endophthalmitis in these special patient populations, especially when they are comorbid with other potential CV risk factors.
Keyphrases
- acute myocardial infarction
- end stage renal disease
- ankylosing spondylitis
- ejection fraction
- risk factors
- newly diagnosed
- chronic kidney disease
- prognostic factors
- primary care
- rheumatoid arthritis
- left ventricular
- systemic lupus erythematosus
- percutaneous coronary intervention
- climate change
- case report
- patient reported
- human health